Lenalidomide Maintenance for High Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (alloHCT) with reduced intensity conditioning is an appealing option for patients with high risk multiple myeloma (MM). However, progression after alloHCT remains a challenge. Maintenance therapy after alloHCT may offer additional disease control and all...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Alsina, Melissa, Becker, Pamela S., Zhong, Xiaobo, Adams, Alexia, Hari, Parameswaran, Rowley, Scott, Stadtmauer, Edward A., Vesole, David H., Logan, Brent, Weisdorf, Daniel, Qazilbash, Muzaffar, Popplewell, Leslie L., McClune, Brian, Bensinger, William, Riches, Marcie, Giralt, Sergio A., Pasquini, Marcelo C.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036168/
https://ncbi.nlm.nih.gov/pubmed/24769014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.04.014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares